Editorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsoredEditorially independent36 providers reviewedUpdated monthlyAffiliate-supported, never sponsored

FDA-approved · 2023

Zepbound

Generic: Tirzepatide · Manufactured by Eli Lilly

FDA-approved for chronic weight management. Same active ingredient as Mounjaro (tirzepatide). Shows the highest average weight loss of any currently approved GLP-1 medication.

Avg weight loss

20-22% of body weight

Monthly price

$1,060

With insurance

Varies by plan

Approved

2023

How it works

Mechanism
Dual GLP-1/GIP receptor agonist
Administration
Weekly subcutaneous injection
Doses
2.5mg to 15mg (weekly injection)
Approved for
Chronic weight management
Self-pay options
LillyDirect program for eligible patients
Oral version
Injection only

Where to get Zepbound online

The 5 top-rated providers we’ve reviewed that prescribe Tirzepatide.